title: Reply: To PMID 24846806.
authors.affiliation: Iowa City, Iowa.
authors.forename: Chakradhari
authors.initials: C
authors.lastname: Inampudi
authors.affiliation: Fresno, California.
authors.forename: Prakash
authors.initials: P
authors.lastname: Deedwania
authors.affiliation: Los Angeles, California.
authors.forename: Gregg C
authors.initials: GC
authors.lastname: Fonarow
authors.affiliation: Birmingham, Alabama.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Sanders
authors.affiliation: Valhalla, New York.
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
authors.affiliation: Washington, DC.
authors.forename: Ali
authors.initials: A
authors.lastname: Ahmed
mesh_terms: D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010359:Patient Readmission / Q000706:statistics & numerical data*; D013148:Spironolactone / Q000627:therapeutic use*
chemical_list: D004232:Diuretics; D013148:Spironolactone